This medication should not be taken for more than 3 days. If the pain does not improve after 3 days, ask your doctor for advice.
Never exceed the maximum recommended dose.
Paracetamol/Codeine Farmalider should be taken orally. The ingestion of the tablets can be helped with a sip of water or another non-alcoholic liquid.
The administration of the preparation is subject to the appearance of painful or feverish symptoms. As these symptoms disappear, this medication should be discontinued.
Patients with liver disease:Before taking this medication, they must consult their doctor.
They should take the amount of medication prescribed by their doctor with a minimum interval of 8 hours between each dose. They should not take more than 2 grams of paracetamol in 24 hours (4 tablets), divided into several doses.
Patients with kidney disease:Before taking this medication, they must consult their doctor.
Depending on their disease, their doctor will indicate if they should take the medication with a minimum interval of 6 or 8 hours. They should not take more than 2 grams in 24 hours (4 tablets), divided into several doses, without exceeding 500 milligrams per dose.
Patients of advanced age:Before taking this medication, they must consult their doctor.
If they estimate that the action of Paracetamol/Codeine Farmalider is too strong or too weak, they should inform their doctor or pharmacist.
If you take more Paracetamol/Codeine Farmalider than you should
If you have taken more Paracetamol/Codeine Farmalider than you should, consult your doctor or pharmacist immediately, or call the Toxicological Information Service, telephone 915 620 420, indicating the medication and the amount ingested.
If a overdose has been taken, you should go to a medical center immediately, even if there are no symptoms, as they often do not appear until 3 days after the overdose, even in cases of severe intoxication.
The treatment of an overdose is more effective if it is initiated within 4 hours of taking the medication.
A paracetamol overdose is considered to be the ingestion of a single dose of more than 6 grams in adults (12 tablets of Paracetamol/Codeine Farmalider) and more than 100 milligrams per kilogram of weight in children (for a child of 20 kilograms, 4 tablets in a single dose).
The symptoms of a paracetamol overdose may be: dizziness, vomiting, loss of appetite, yellowing of the skin and eyes (jaundice), abdominal pain.
The symptoms of a codeine overdose may be: initial excitement, anxiety, inability to fall asleep (insomnia) and subsequently in certain cases a feeling of sleepiness (somnolence), headache (cephalalgia), alterations in blood pressure, arrhythmias, dry mouth, skin eruptions, tachycardia, convulsions, gastrointestinal disturbances, nausea, vomiting and respiratory depression.
If you forgot to take Paracetamol/Codeine Farmalider
Do not take a double dose to compensate for the missed doses. Take the missed dose as soon as you remember and if your next dose is due soon, omit the missed dose and continue taking the medication at the usual time. If in doubt, consult your doctor or pharmacist.
If you have any other questions about the use of this medication, ask your doctor or pharmacist.
Like all medicines, this medicine may cause side effects, although not everyone will experience them.
The observed side effects are described below according to their frequency of presentation:
Very frequent (may affect more than 1 in 10 people), frequent (may affect up to 1 in 10 people), infrequent (may affect up to 1 in 100 people), rare (may affect up to 1 in 1000 people), and very rare (may affect up to 1 in 10,000 people).
The following side effects have been observed caused by paracetamol:
Rare:Discomfort, increased levels of liver transaminases (liver enzymes), hypotension (decreased blood pressure),
Very rare:Allergic reactions (hypersensitivity) ranging from a simple skin rash (redness or inflammation of the skin) or urticaria (hives) to anaphylactic shock (a type of severe allergic reaction), hepatotoxicity (liver toxicity), jaundice (yellow discoloration of the skin and mucous membranes), hypoglycemia (low blood glucose levels), thrombocytopenia (reduced platelet count in the blood), agranulocytosis, leukopenia, neutropenia (reduced white blood cell count), hemolytic anemia (reduced red blood cell count), sterile pyuria (cloudy urine), adverse renal effects.
The following side effects have also been described caused by codeine:
Rare: Discomfort, drowsiness, constipation, and nausea.
Very rare:Allergic reactions (hypersensitivity) ranging from a simple skin rash (redness or inflammation of the skin) or urticaria (hives) to anaphylactic shock (a type of severe allergic reaction), fever, yellow discoloration of the skin and eyes (jaundice), low blood glucose levels (hypoglycemia), blood abnormalities. Rarely, severe skin reactions have been reported.
Unknown frequency(cannot be estimated from available data): A serious disease that can cause the blood to become more acidic (metabolic acidosis) in patients with severe disease who use paracetamol (see section 2).
Reporting of side effects
If you experience any type of side effect, consult your doctor or pharmacist, even if it is a possible side effect that does not appear in this leaflet. You can also report them directly through the national notification system included inwww.notificaRAM.es. By reporting side effects, you can contribute to providing more information on the safety of this medicine.
This medication does not require special storage conditions.
Keep this medication out of the sight and reach of children.
Do not use this medication after the expiration date that appears on the packaging after CAD. The expiration date is the last day of the month indicated.
Medications should not be disposed of through drains or in the trash. Dispose of the packaging and medications you no longer need at the SIGRE collection point at the pharmacy. Ask your pharmacist how to dispose of the packaging and medications you no longer need. This will help protect the environment.
Composition of Paracetamol/Codeína Farmalider
Appearance of the product and contents of the packaging
Each package contains 20 tablets. The medication is presented conditioned in PVC/PVDC-white opaque/Al blisters.
Holder of the marketing authorization and responsible for the manufacturing
Holder of the marketing authorization
FARMALIDER S.A.
C/ Aragoneses 15
28108 – Alcobendas (Madrid)
Responsible for the manufacturing
FARMALIDER S.A.
C/ Aragoneses 15
28108 – Alcobendas (Madrid)
or
TOLL MANUFACTURING SERVICES S.L..
C/ Aragoneses 2
28108 – Alcobendas (Madrid)
Revision date of this prospectus: March 2025
The detailed information of this medication is available on the webpage of the Spanish Agency of Medicines and Medical Devices (AEMPS)http://www.aemps.es/
Have questions about this medication or your symptoms? Connect with a licensed doctor for guidance and personalized care.